Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Monday, October 11, 2021 10:10:32 AM
...the reporting of (clearly conflicting statements) alleged events which are not even known to IPIX or LEO based upon ... a double-blinded study is not worth concern...
IMO ...the only anecdotal evidence of Brilacidin's efficacy OUTSIDE OF THE CLINICAL TRIALS...could only possibly come from "Compassionate Use" cases from Drs. who report back (and they must) to FDA on each case.
To qualify for Compassionate Use, by definition the patient has to be in CRITICAL CONDITION...on or about to go on a ventilator. There still is a 95% death rate for those on ventilators. 1 in 20 chance of surviving...
If after being administered Brilacidin in the dosage recommended or increased as requested by patient's physician...and survival occurs with Brilacidin as the patient walk's out of the hospital on his or her own accord...it would raise eyebrows at the hospital but it could simply be the 1 in 20 that make it. But if thereafter more Brilacidn Compassionate Use Patients survive ... IT WOULD RAISE MORE THAN AN EYEBROW...it would appear to be somewhat of a miracle, for example, if 4 out of 5 survived (assuming one on Facebook who reportedly died had full dosage...which some reported she did not) ... If ALL FULL DOSAGE PATIENTS, walked out of the hospital...AFTER BRILACIDIN...IMO the FDA would review that data IMO immediately WITH the TOPLINE deadline in considering EUA.
Without knowing the exact number of Brilacidin Compassionate Use "Critical Condition" survivors who received full dosing of Brilacidin ...it is conjecture as to whether Brilacidin's Compassionate Use results were the INVERSE of or at significantly better than SOC (ventilators/steroids) in those hospitals...
Perhaps the inquiry by the poster who was close to Admin at the Miami HospitalS could find out how many Brilacidin Compassionate Use patients survived and walked out the door.
IMO...that positive information is Worth at least $5.00 for starters...
Days away from Top Line results...
Know what you own!
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM